Arley Ruskin

Arley Ruskin is currently listed as Chief of Staff and Director of Strategy & Operations - Partnerships at Grow Therapy, a mental health platform that connects clients with therapists and psychiatric medication providers, with insurance-based search and booking tools. The Org lists Ruskin as having joined Grow Therapy in May 2023.

Before Grow Therapy, Ruskin worked at Dandy from March 2021 to April 2023, first after leaving private equity and later in strategy, pricing, and special projects / Chief of Staff to the COO roles according to profile aggregators. Dandy is not an investing firm, so this appears to mark Ruskin’s move from finance into operating roles.

Ruskin’s investing experience was at Palladium Equity Partners, where The Org lists a Private Equity Associate role from January 2020 to March 2021. Palladium is a New York-based middle-market private equity firm founded in 1997, focused on consumer, services, industrials, and healthcare companies, with a particular emphasis on U.S. Hispanic market opportunities and founder/family-owned businesses.

Earlier, Ruskin worked at RBC Capital Markets from 2017 to 2020 as an investment banking analyst and associate, including prior summer analyst experience in the Consumer & Retail Group. Ruskin holds both a Master of Science in Finance and a Bachelor of Science in Business Administration - Finance from the University of Florida.

• Ruskin is not publicly listed as a current investor at Palladium as of the latest sources found; the public profile shows a current operating role at Grow Therapy and a prior Palladium associate role.
• Palladium’s Flagship strategy invests $50-$150 million of equity capital into U.S. companies with $10-$75 million of EBITDA.
• Palladium describes itself as investing across “consumer, services, industrials, and healthcare.”
• Palladium is control-oriented and uses common or preferred equity with some mezzanine debt.
• Palladium states that it often provides first institutional capital to founder- and family-owned businesses.
• Themes highlighted by Palladium include evolving supply chains, health and wellness, the U.S. Hispanic market, and growth through acquisition.
• The stub’s “Seed Round” / “Angel Investors” classification is not supported by the stronger public sources found; the verifiable investing background is middle-market private equity, not seed-stage angel investing.